YOUR CONDITION, EXPLAINED
Chronic Liver Disease Without Cirrhosis VA disability rating & claim guide
The VA rates Chronic Liver Disease Without Cirrhosis under diagnostic code 7345, in 38 CFR § 4.114 (digestive system), and the schedule provides five evaluation levels for it: 100%, 60%, 40%, 20% and 0%.
Free · No account needed
Save your Chronic Liver Disease Without Cirrhosis guide
Email yourself this Chronic Liver Disease Without Cirrhosis guide so the rating criteria, evidence checklist, and preparation tips are easy to find later.
A CLEARER PATH FORWARD
Make sense of your next step.
01Understand the rating02Know what to gather03Plan your preparationTHE ESSENTIALS
How the VA rates Chronic Liver Disease Without Cirrhosis
DC 7345 is the code the digestive schedule uses for chronic liver disease that has not become cirrhosis, and Note (3) says what it covers: hepatitis B confirmed by serologic testing, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune liver disease, Wilson's disease, alpha-1-antitrypsin deficiency, hemochromatosis, drug-induced hepatitis, and non-alcoholic steatohepatitis. Hepatitis C is tracked under its own code, DC 7354, but evaluated on these criteria. The ladder turns on three things and nothing else: whether the disease is progressive and requires continuous medication, whether there is minor or substantial weight loss, and how many of six named symptoms are present. The top tier is about treatment rather than symptoms — both parenteral antiviral and parenteral immunomodulatory therapy at once.
DC 7345 states five evaluations. 0 percent: previous history of liver disease, currently asymptomatic. 20 percent: chronic liver disease with at least one of intermittent fatigue, malaise, anorexia, hepatomegaly, or pruritus. 40 percent: progressive chronic liver disease requiring continuous medication and causing minor weight loss and at least two of daily fatigue, malaise, anorexia, hepatomegaly, pruritus, and arthralgia. 60 percent: the same criterion with substantial weight loss in place of minor. 100 percent: progressive chronic liver disease requiring use of both parenteral antiviral therapy (direct antiviral agents) and parenteral immunomodulatory therapy (interferon and other), and for six months following discontinuance of treatment. Read down the ladder, three things change and they change in step: the symptom list goes from five to six items with arthralgia added at 40 percent, the count goes from one to two, and the word for fatigue goes from intermittent to daily. Continuous medication and weight loss appear only at 40 and above, which is why a symptomatic claim without either sits at 20. Four notes govern the rest. Note (1): the 100 percent evaluation shall continue for six months following discontinuance of parenteral antiviral therapy and administration of parenteral immunomodulatory drugs; six months after that discontinuance, the appropriate disability rating is determined by mandatory VA examination, and 38 CFR 3.105(e) applies to any change in evaluation based on that or any subsequent examination. Note (2): for individuals for whom physicians recommend both parenteral antiviral therapy and parenteral immunomodulatory drugs, but for whom treatment is medically contraindicated, rate according to DC 7312 (cirrhosis of the liver). Note (3): this diagnostic code includes hepatitis B (confirmed by serologic testing), primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune liver disease, Wilson's disease, alpha-1-antitrypsin deficiency, hemochromatosis, drug-induced hepatitis, and non-alcoholic steatohepatitis; track hepatitis C (or non-A, non-B hepatitis) under DC 7354 but evaluate it using the criteria in this entry. Note (4): evaluate sequelae, such as cirrhosis or malignancy of the liver, under an appropriate diagnostic code, but do not use the same signs and symptoms as the basis for evaluation under DC 7354 and under a diagnostic code for sequelae, citing 38 CFR 4.14. One rule from outside the code matters as much as its own tiers. The introductory paragraph of 38 CFR 4.114 says not to combine ratings under diagnostic codes 7301 through 7329 inclusive, 7331, 7342, 7345 through 7350 inclusive, 7352, and 7355 through 7357 with each other; where more than one would be warranted, a single evaluation is assigned under the code that reflects the predominant disability picture, elevated to the next higher evaluation if the severity of the overall disability warrants it. DC 7345 is in that list and so is DC 7312, so chronic liver disease and cirrhosis are not two ratings that add together.
- Diagnostic code
- 7345
- Rating schedule
- 38 CFR § 4.114
- Schedule levels
- 100%, 60%, 40%, 20% and 0%
How does the VA choose a rating level?
Which level applies is set by the criteria the evidence meets, not by the diagnosis. Where there is a question as to which of two evaluations applies, 38 CFR § 4.7 assigns the higher one if the disability picture more nearly approximates the criteria required for that rating.
EXPLORE THE PERCENTAGES
Chronic Liver Disease Without Cirrhosis VA rating criteria (DC 7345)
Choose a percentage to see what that level means. Open the full comparison to read all the criteria in one place.
These are published rating criteria. Selecting a level does not predict your VA decision.
IN THE REGULATION’S OWN WORDS
What 38 CFR also says about Chronic Liver Disease Without Cirrhosis
The notes 38 CFR Part 4 prints with these criteria, quoted. They govern how the evaluation is made without being a rating level themselves.
- “Note (1): 100% evaluation shall continue for six months following discontinuance of parenteral antiviral therapy and administration of parenteral immunomodulatory drugs. Six months after discontinuance of parenteral antiviral therapy and parenteral immunomodulatory drugs, determine the appropriate disability rating by mandatory VA exam. Apply the provisions of § 3.105(e) of this chapter to any change in evaluation based upon that or any subsequent examination.”DC 7345
- “Note (2): For individuals for whom physicians recommend both parenteral antiviral therapy and parenteral immunomodulatory drugs, but for whom treatment is medically contraindicated, rate according to DC 7312 (Cirrhosis of the liver).”DC 7345
- “Note (3): This diagnostic code includes Hepatitis B (confirmed by serologic testing), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), autoimmune liver disease, Wilson's disease, Alpha-1-antitrypsin deficiency, hemochromatosis, drug-induced hepatitis, and non-alcoholic steatohepatitis (NASH). Track Hepatitis C (or non-A, non-B hepatitis) under DC 7354 but evaluate it using the criteria in this entry.”DC 7345
- “Note (4): Evaluate sequelae, such as cirrhosis or malignancy of the liver, under an appropriate diagnostic code, but do not use the same signs and symptoms as the basis for evaluation under DC 7354 and under a diagnostic code for sequelae. (See § 4.14)”DC 7345
BUILD YOUR EVIDENCE, ONE PIECE AT A TIME
Evidence for your Chronic Liver Disease Without Cirrhosis claim
A long list feels easier when you have a place to start. Use this checklist to see what you have and what still needs gathering.
Check off what you’ve gathered. Progress stays on this page until you leave or refresh.
THE EXAM FORM
Which DBQ is used for Chronic Liver Disease Without Cirrhosis?
VA's page says: “You can use these forms to submit medical evidence from your health care providers.”
Source: VA: Public Disability Benefits Questionnaires (DBQs), read September 18, 2026.
SMALL DETAILS. BETTER PREPARATION.
Preparing your Chronic Liver Disease Without Cirrhosis claim
Start with the practical tips, then explore the common oversights. You don’t need to work through everything at once.
Practical tips for your claim4 tips
- 01
Keep the symptom list itself in front of the examiner. Six words decide four of the five tiers — fatigue, malaise, anorexia, hepatomegaly, pruritus and arthralgia — and the count is what the criteria are made of.
- 02
Ask that weight be recorded at each visit. Minor against substantial weight loss is the whole distance between 40 and 60 percent under this code.
- 03
Put the treatment history in with dates. Both the 100 percent criterion and Note (1)'s six-month continuation are written about specific therapies and the date they stopped.
- 04
Check 38 CFR 4.114's introductory paragraph before adding a second digestive claim. Where more than one code in its list is warranted, the schedule assigns one evaluation under the predominant disability picture and elevates it if the overall severity warrants, which is a different argument from claiming two.
C&P exam pitfalls to keep in mind4 tips
- 01
Symptoms summarized as a group instead of named and counted. This code's tiers are built on how many items from a specific list are present, so "fatigue and GI symptoms" cannot be placed against them.
- 02
Fatigue recorded without saying whether it is intermittent or daily. That single word separates the 20 percent list from the 40 and 60 percent list.
- 03
Treatment described without saying whether it was parenteral and whether both kinds were used. The 100 percent criterion requires both parenteral antiviral therapy and parenteral immunomodulatory therapy, and nothing less reaches it.
- 04
No date of discontinuance for treatment. Note (1) runs the 100 percent for six months past that date and then makes a VA examination mandatory, so the date is what the schedule is counting from.
Common filing mistakes4 tips
- 01
Filing hepatitis C under this code. Note (3) says to track hepatitis C (or non-A, non-B hepatitis) under DC 7354 while evaluating it using the criteria in this entry, so the criteria are shared and the code is not.
- 02
Claiming this code and cirrhosis as two ratings. 38 CFR 4.114's introductory paragraph lists both DC 7345 and DC 7312 among the codes that are not combined with each other; a single evaluation is assigned under the predominant disability picture.
- 03
Treating a contraindication as the end of the claim. Note (2) covers exactly that case: where physicians recommend both therapies but treatment is medically contraindicated, the evaluation is made according to DC 7312.
- 04
Claiming a sequela on the same findings that already support this code. Note (4) allows sequelae such as cirrhosis or malignancy of the liver to be evaluated under an appropriate code but forbids using the same signs and symptoms twice, citing 38 CFR 4.14.
When symptoms may first appear2 tips
- 01
The schedule states no course of onset for this code. Its tiers describe a present picture — progressive or not, on continuous medication or not, with a named set of symptoms — rather than a history, and the 0 percent tier is the one that is written about history alone.
- 02
The interval the regulation fixes is six months. Note (1) continues the 100 percent evaluation for six months following discontinuance of parenteral antiviral therapy and parenteral immunomodulatory drugs, then makes a VA examination mandatory, with 38 CFR 3.105(e) applying to any change that examination produces.
SECONDARY TO SOMETHING ELSE
Conditions that can lead to Chronic Liver Disease Without Cirrhosis
Each links to a page on claiming Chronic Liver Disease Without Cirrhosis as secondary to that condition.
LET’S CLEAR A FEW THINGS UP
Common questions about Chronic Liver Disease Without Cirrhosis
Is Chronic Liver Disease Without Cirrhosis a VA-rated disability?
Yes. The VA rates Chronic Liver Disease Without Cirrhosis under VASRD diagnostic code 7345 (Digestive System). DC 7345 is the code the digestive schedule uses for chronic liver disease that has not become cirrhosis, and Note (3) says what it covers: hepatitis B confirmed by serologic testing, primary biliary cirrhosis, primary sclerosing cholangitis, autoimmune liver disease, Wilson's disease, alpha-1-antitrypsin deficiency, hemochromatosis, drug-induced hepatitis, and non-alcoholic steatohepatitis. Hepatitis C is tracked under its own code, DC 7354, but evaluated on these criteria. The ladder turns on three things and nothing else: whether the disease is progressive and requires continuous medication, whether there is minor or substantial weight loss, and how many of six named symptoms are present. The top tier is about treatment rather than symptoms — both parenteral antiviral and parenteral immunomodulatory therapy at once.
What VA disability rating can I get for Chronic Liver Disease Without Cirrhosis?
Possible VA ratings for Chronic Liver Disease Without Cirrhosis are 100%, 60%, 40%, 20%, 0%. Examples: 100%: Progressive chronic liver disease requiring use of both parenteral antiviral therapy (direct antiviral agents), and parenteral immunomodulatory therapy (interferon and other); and for six months following discontinuance of treatment; 60%: Progressive chronic liver disease requiring continuous medication and causing substantial weight loss and at least two of the following: (1) daily fatigue, (2) malaise, (3) anorexia, (4) hepatomegaly, (5) pruritus, and (6) arthralgia; 40%: Progressive chronic liver disease requiring continuous medication and causing minor weight loss and at least two of the following: (1) daily fatigue, (2) malaise, (3) anorexia, (4) hepatomegaly, (5) pruritus, and (6) arthralgia.
What evidence helps prove Chronic Liver Disease Without Cirrhosis for VA disability?
Strong evidence for a Chronic Liver Disease Without Cirrhosis claim includes: A symptom record that names which of the listed symptoms are present and how often. The 20 percent tier asks for at least one of intermittent fatigue, malaise, anorexia, hepatomegaly, or pruritus, and the 40 and 60 percent tiers ask for at least two of daily fatigue, malaise, anorexia, hepatomegaly, pruritus, and arthralgia — different lists and different counts; Weights recorded over time rather than a single weight. The only difference between the 40 and 60 percent criteria is minor weight loss against substantial weight loss, so the file has to show a trajectory; The medication record, stating whether medication is continuous and, for the top tier, whether both parenteral antiviral therapy and parenteral immunomodulatory therapy were used. Note (1) also makes the date treatment was discontinued a dated fact the evaluation depends on; The specific diagnosis, because Note (3) decides which code the claim is tracked under. Hepatitis B and non-alcoholic steatohepatitis belong here; hepatitis C is tracked under DC 7354 and evaluated on these same criteria.
Which DBQ is used for Chronic Liver Disease Without Cirrhosis?
VA's Liver Conditions Disability Benefits Questionnaire (DBQ) is on its public list of DBQs. VA's page says: "You can use these forms to submit medical evidence from your health care providers."
What mistakes should veterans avoid when claiming Chronic Liver Disease Without Cirrhosis?
Common pitfalls when filing for Chronic Liver Disease Without Cirrhosis: Filing hepatitis C under this code. Note (3) says to track hepatitis C (or non-A, non-B hepatitis) under DC 7354 while evaluating it using the criteria in this entry, so the criteria are shared and the code is not; Claiming this code and cirrhosis as two ratings. 38 CFR 4.114's introductory paragraph lists both DC 7345 and DC 7312 among the codes that are not combined with each other; a single evaluation is assigned under the predominant disability picture; Treating a contraindication as the end of the claim. Note (2) covers exactly that case: where physicians recommend both therapies but treatment is medically contraindicated, the evaluation is made according to DC 7312; Claiming a sequela on the same findings that already support this code. Note (4) allows sequelae such as cirrhosis or malignancy of the liver to be evaluated under an appropriate code but forbids using the same signs and symptoms twice, citing 38 CFR 4.14.
Is hepatitis C rated under DC 7345 or DC 7354?
Both, and the distinction is not cosmetic. Note (3) of DC 7345 says to track hepatitis C (or non-A, non-B hepatitis) under DC 7354 but to evaluate it using the criteria in the DC 7345 entry. So a rating decision on hepatitis C cites DC 7354, and the percentage it assigns comes from this code's ladder. DC 7354's own entry in the schedule states no criteria at all - its whole text is "Rate under DC 7345 (Chronic liver disease without cirrhosis)". The practical consequence is that the evidence for a hepatitis C claim and for a hepatitis B claim is the same evidence: whether the disease is progressive, whether continuous medication is required, what the weight trend is, and which of daily fatigue, malaise, anorexia, hepatomegaly, pruritus and arthralgia are present.
Can I be rated for chronic liver disease and cirrhosis at the same time?
No. The introductory paragraph of 38 CFR 4.114 lists both DC 7345 and DC 7312 among the digestive codes that are not combined with each other. Where more than one of them would be warranted, a single evaluation is assigned under the diagnostic code that reflects the predominant disability picture, and it is elevated to the next higher evaluation if warranted by the severity of the overall disability. That elevation is the argument worth making, rather than a second rating. Note (4) of DC 7345 points the same way for sequelae: cirrhosis or malignancy of the liver can be evaluated under an appropriate code, but the same signs and symptoms may not be used as the basis for both, citing 38 CFR 4.14.
Official sources
- 38 CFR § 4.114, Schedule of ratings, digestive system (Diagnostic Code 7345)
- 38 CFR § 4.7, higher of two evaluations
Criteria in quotation marks are the regulation’s own words; everything else on this page is Vetrify’s summary of it. The eCFR text is authoritative. See how Vetrify derives its numbers.
How these figures are checked: our methodology and the open dataset.
VA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline